DHEAS and POMS measures identify cocaine dependence treatment outcome
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 30 (1) , 18-28
- https://doi.org/10.1016/j.psyneuen.2004.04.006
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Participants Receiving Dehydroepiandrosterone During Treatment for Cocaine Dependence Show High Rates of Cocaine Use in a Placebo-Controlled Pilot Study.Experimental and Clinical Psychopharmacology, 2004
- Elevation of the Cortisol-Dehydroepiandrosterone Ratio in Drug-Free Depressed PatientsAmerican Journal of Psychiatry, 2002
- Plans, Designs, and Analyses for Clinical Trials of Anti-Cocaine MedicationsJournal of Clinical Psychopharmacology, 1999
- Assessment of cocaine use with quantitative urinalysis and estimation of new usesAddiction, 1997
- Dehydroepiandrosterone sulphate in critical illness: effect of dopamineClinical Endocrinology, 1995
- Salivary cortisol in psychoneuroendocrine research: Recent developments and applicationsPublished by Elsevier ,1994
- Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiographyJournal of the American College of Cardiology, 1990
- Developmental processes in early adolescence: Relationships between adolescent adjustment problems and chronologic age, pubertal stage, and puberty-related serum hormone levelsThe Journal of Pediatrics, 1987
- A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular DiseaseNew England Journal of Medicine, 1986
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986